MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Analysts are now discussing an updated €8 price target for ...

This is part of a series of stories on the protective role of innate lymphoid cells (ILCs) in the gut and other tissues, focusing on SARS-CoV-2 infection. One area that hasn’t received all that much ...

Although many anticancer immunotherapies have focused on the adaptive immune system, the innate immune system also plays important roles in the immune response against cancer. The cells of the innate ...

The immune system can work in two ways: the innate immune system reacts to any foreign invaders that are identified by immune cells that look for such pathogens; but the acquired or adaptive immune ...

The human immune system is split into the innate immune system and the adaptive immune system. Both systems work in harmony to protect us from infections and disease. Here, we discuss their ...

View Innate Pharma SA Sponsored ADR IPHA stock quote prices, financial information, real-time forecasts, and company news from CNN.

Foal pneumonia is one of the leading causes of disease and death in foals, with severe cases being most commonly caused by the bacterium Rhodococcus equi (R. equi). A research team at the University ...

Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three ...

The BCG vaccine protects against tuberculosis, but by inducing trained immunity it also protects against many more respiratory infections. International research led by Radboud University Medical ...

Innate Pharma (IPHA) announced the publication in Science Immunology of preclinical data demonstrating the potential of IPH6501, Innate’s proprietary NK cell engager including an IL-2v and targeting ...